11/24/2021BeiGene Completes Acquisition of Former BMS Campus in NJ

11/24/2021API Manufacturers Targeted by China's New Anti-monopoly Bureau: Pharma...

11/23/2021PharmaDJ's China Licensing Deals Tracker: October 2021

11/23/2021NHC Issues Notice on Promotion of Sanming City's Healthcare Reform Exp...

11/23/2021Ji Xing Granted Chinese IND Approval for Phase 1 & 3 Trials of Etripam...

11/23/2021Lonza and Bluejay Therapeutics Ink Manufacturing Deal

11/23/2021Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from...

11/22/2021CStone and Hengrui Enter Licensing Pact on Anti-CTLA-4 mAb CS1002 in ...

11/22/2021Independent Directors of Kangmei Pharma Fined Heavily, Triggering A Qu...

11/22/2021Sanofi and Baidu Enter License Agreement for Next-Generation mRNA Th...

11/19/2021GSK Secures Chinese Approval of Nucala (mepolizumab) for EPGA

11/19/2021State Council Issues the Opinions for Improving Critical Illness Medic...

11/18/2021Performance Data Review of A Share-Listed Chinese Healthcare Companies...

11/18/2021Data Review of Chinese Public Medical Institution Drug Sales in H1/202...

11/18/2021Bright Peak Licenses Livzon's Antibody LZM009 to Develop Novel PD-1 Ta...

11/18/2021China Launches the State Anti-monopoly Bureau as It Issues the Guideli...

11/18/2021China Healthcare Summit: Western Investors Expand into Chinese Biotech...

11/17/2021Kangmei Pharma Executives Sentenced to Jail

11/16/2021I-Mab and Jumpcan Announce Strategic Commercial Partnership on Eftanso...

11/16/2021Amgen Enters into Strategic Collaboration with Profex to Co-promote Pr...

11/16/2021Innovent's 5th NDA for PD-1 Drug Tyvyt Turned Down by the NMPA 

11/16/2021Janssen Secures Third Chinese Approval for Darzalex to Treat Newly Dia...

11/16/2021PharmaDJ's China Biotech Fundraising Tracker: October 2021

11/16/2021PharmaDJ: Chinese American Physicians and Scientists Foster Exchanges ...

11/15/2021China In The Global Pharmaceutical Innovation Race

11/15/2021Luye Pharma Grants Zambon Swiss Rights of Its Alzheimer's Drug Rivas...

11/15/2021Milestone's Chinese Partner Files Chinese IND for Etripamil

11/15/2021China to Release the Updated NRDL Soon

11/15/2021Chinese Court Rules against Kangmei Pharma in 'Milestone' Case

11/15/2021HebaBiz Biotech's P3 Trial in China for HBV Drug Clevudine (L-FMAU) ...

Page:77/356 Total number of articles:10680: [First][<<] [75] [76] [77] [78] [79] [>>] [End]